TF
Terence Flynn Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
64
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
47.1%
Neutral
47.1%
Negative
5.9%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $1,313 |
34%
upside
| 1 | +5.7% |
0
%
| 5 Feb ‘26 28 days ago |
|
|
|
Overweight
Maintained
| $270 |
16%
upside
| 2 | +6% |
0
%
| 5 Feb ‘26 28 days ago |
|
|
|
Equal-Weight
Maintained
| $309 |
16%
downside
| 2 | – |
–
| 4 Feb ‘26 29 days ago |
|
|
|
Overweight
Upgraded
| $262 |
9%
upside
| 3 | +6.8% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Equal-Weight
Downgraded
| $20 |
10%
downside
| 1 | +172% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Overweight
Upgraded
| $36 |
137%
upside
| 1 | -18% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $33 |
19%
upside
| 1 | +170% |
0
%
| 7 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $21 |
104%
upside
| 1 | -18% |
0
%
| 6 Jan ‘26 1 month ago |
|
|
|
Equal-Weight
Maintained
| $27 |
1%
upside
| 2 | – |
–
| 17 Dec ‘25 2 months ago |
|
|
|
Underweight
Maintained
| $37 |
39%
downside
| 1 | -13% |
0
%
| 12 Dec ‘25 2 months ago |
|
|
|
Equal-Weight
Maintained
| $102 |
12%
downside
| 1 | -2.8% |
0
%
| 12 Dec ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $125 |
109%
upside
| 1 | -11% |
0
%
| 12 Dec ‘25 2 months ago |
|